Report #2850285

Received Jul 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: CA
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Rash

Symptom narrative

developed a rash/ general rash on chest; This non-serious case was reported by a other health professional via sales rep and described the occurrence of rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown deltoid). On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: developed a rash/ general rash on chest). The outcome of the rash was resolved. The reporter considered the rash to be related to Shingrix. The company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date: 09-JUL-2025 The physician assistant that they had a patient who developed a rash after the 1st dose of Shingrix injection and was general rash on chest that lasted a few weeks.